| Literature DB >> 23481676 |
Chi-Jen Tai1, Jui-Hsin Su, Chiung-Yao Huang, Ming-Shyan Huang, Zhi-Hong Wen, Chang-Feng Dai, Jyh-Horng Sheu.
Abstract
Five new eunicellin-based diterpenoids, krempfielins E-I (1-5) and seven known compounds (6-12) were isolated from the organic extract of a Taiwanese soft coral Cladiella krempfi. The structures of the new metabolites were elucidated on the basis of extensive spectroscopic analysis. Metabolites 5, 6, 10 and 12 were shown to exhibit cytotoxicity against a limited panel of cancer cell lines. Furthermore, compounds 6 and 10 could potently inhibit the accumulation of the pro-inflammatory iNOS protein, and 6 and 12 could significantly reduce the expression of COX-2 protein in LPS-stimulated RAW264.7 macrophage cells.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23481676 PMCID: PMC3705370 DOI: 10.3390/md11030788
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Chart 1Structures of metabolites 1–12.
13C NMR Data for Compounds 1–5.
| C | 1 a | 2 a | 3 b | 4 b | 5 a |
|---|---|---|---|---|---|
| 1 | 43.3, CH c | 45.8, CH | 44.7, CH | 44.9, CH | 46.6, CH |
| 2 | 91.4, CH | 90.6, CH | 90.9, CH | 90.8, CH | 92.6, CH |
| 3 | 84.4, C | 84.7, C | 84.2, C | 84.6, C | 85.6, C |
| 4 | 28.4, CH2 | 33.2, CH2 | 33.2, CH2 | 32.6, CH2 | 35.8, CH2 |
| 5 | 35.3, CH2 | 30.2, CH2 | 29.7, CH2 | 38.3, CH2 | 28.5, CH2 |
| 6 | 66.9, CH | 214.8, C | 217.0, C | 213.4, C | 82.3, CH |
| 7 | 152.2, C | 48.3, CH | 40.7, CH | 40.6, CH | 78.0, C |
| 8 | 77.3, CH | 42.4, CH2 | 78.5, CH | 37.7, CH2 | 78.5, CH |
| 9 | 83.7, CH | 81.9, CH | 85.5, CH | 78.9, CH | 78.3, CH |
| 10 | 47.9, CH | 52.1, CH | 47.5, CH | 49.4, CH | 52.0, CH |
| 11 | 145.2, C | 142.1, C | 141.0, C | 141.6, C | 148.5, C |
| 12 | 31.3, CH2 | 73.1, CH | 72.8, CH | 73.0, CH | 31.6, CH2 |
| 13 | 25.7, CH2 | 28.5, CH2 | 28.9, CH2 | 28.7, CH2 | 25.5, CH2 |
| 14 | 39.1, CH | 35.3, CH | 35.6, CH | 35.7, CH | 44.0, CH |
| 15 | 22.2, CH3 | 22.3, CH3 | 22.6, CH3 | 22.6, CH3 | 22.8, CH3 |
| 16 | 118.1, CH2 | 17.8, CH3 | 14.1, CH3 | 15.4, CH3 | 18.5, CH3 |
| 17 | 112.0, CH2 | 118.1, CH2 | 119.5, CH2 | 118.7, CH2 | 109.2, CH2 |
| 18 | 32.6, CH | 28.0, CH | 27.2, CH | 27.5, CH | 29.0, CH |
| 19 | 67.5, CH2 | 21.5, CH3 | 21.6, CH3 | 21.5, CH3 | 21.9, CH3 |
| 20 | 10.6, CH3 | 16.6, CH3 | 14.9, CH3 | 14.9, CH3 | 15.4, CH3 |
| 3- | 172.5, C | 172.5, C | 173.1, C | ||
| 37.4, CH2 | 37.3, CH2 | 36.5, CH2 | |||
| 18.5, CH2 | 18.4, CH2 | 18.4, CH2 | |||
| 13.6, CH3 | 13.7, CH3 | 13.8, CH3 | |||
| 3-OAc | 169.6, C | 169.7, C | |||
| 22.4, CH3 | 22.3, CH3 | ||||
| 6-OAc | 171.6, C | ||||
| 21.4, CH3 | |||||
| 8- | 173.3, C | ||||
| 36.7, CH2 | |||||
| 18.2, CH2 | |||||
| 13.5, CH3 | |||||
| 12-OAc | 170.2, C | 170.1, C | 170.2, C | ||
| 21.6, CH3 | 21.5, CH3 | 21.4, CH3 | |||
| 19-OAc | 171.2, C | ||||
| 21.0, CH3 |
a Spectra recorded at 100 MHz in CDCl3. b Spectra recorded at 125 MHz in CDCl3. c Deduced from DEPT.
1H NMR Data for Compounds 1–5.
| H | 1 a | 2 a | 3 b | 4 b | 5 a |
|---|---|---|---|---|---|
| 1 | 2.25 m | 2.25 dd | 2.28 m | 2.29 m | 2.17 m |
| (12.4, 7.2) | |||||
| 2 | 3.71 br s | 3.67 br s | 3.81 br s | 3.73 br s | 3.63 br s |
| 4 | 1.64 m | 2.03 m | 2.23 m | 2.19 m | 1.96 m |
| 5 | 1.74 m | 1.91 m | 1.25 m | 2.25 m | 1.56 m |
| 6 | 4.73 dd | 5.71 d (5.6) | |||
| (11.2, 4.0) c | |||||
| 7 | 2.58 m | 2.32 m | 2.68 m | ||
| 8 | 4.18 d (3.2) | 1.88 m | 3.77 d (8.5) | 1.87 t (5.0) | 5.27 d (9.2) |
| 2.00 m | 2.24 m | ||||
| 9 | 4.19 d (6.8) | 4.12 ddd | 4.43 d (11.0) | 4.23 dt | 4.11 t (8.8) |
| (11.6, 8.8, 4.4) | (10.0, 5.0) | ||||
| 10 | 2.87 dd | 3.12 t (7.6) | 2.91 t (7.5) | 3.07 td | 3.39 t (7.2) |
| (10.8, 8.0) | (10.0, 1.5) | ||||
| 12 | 2.10 m | 5.49 t (2.8) | 5.52 br s | 5.49 t (2.5) | 2.03 m |
| 2.27 m | 2.23 m | ||||
| 13 | 1.11 m | 1.26 m | 1.32 m | 1.29 m | 1.08 m |
| 14 | 1.55 m | 1.71 m | 1.76 m | 1.71 m | 1.23 m |
| 15 | 1.63 s | 1.40 s | 1.49 s | 1.48 s | 1.38 s |
| 16 | 5.22 s | 1.06 d (7.2) | 1.26 d (6.5) | 1.07 d (7.0) | 1.08 s |
| 5.51 s | |||||
| 17 | 4.65 s | 4.99 d (1.6) | 4.96 s | 4.97 s | 4.51 s |
| 4.81 s | 5.91 d (1.6) | 5.27 s | 5.28 s | 4.64 s | |
| 18 | 2.08 m | 1.76 m | 1.84 m | 1.81 m | 1.69 m |
| 19 | 3.94 t (6.4) | 0.91 d (6.8) | 0.96 d (7.0) | 0.93 d (6.5) | 0.96 d (6.8) |
| 20 | 0.80 s | 0.75 d (6.8) | 0.78 d (7.0) | 0.77 d (6.5) | 0.77 d (6.8) |
| 3- | 2.10 m | 2.28 m | 2.25 m | ||
| 1.57 m | 1.68 m | 1.68 m | |||
| 0.92 t (7.2) | 0.99 t (7.5) | 0.98 t (7.6) | |||
| 3-OAc | 2.18 s | 2.14 s | |||
| 6-OAc | 2.09 s | ||||
| 8- | 2.55 m | ||||
| 1.61 m | |||||
| 0.96 t (7.2) | |||||
| 12-OAc | 2.00 s | 2.03 s | 1.98 s | ||
| 19-OAc | 2.07 s |
a Spectra recorded at 400 MHz in CDCl3. b Spectra recorded at 500 MHz in CDCl3. c J values (Hz) in parentheses.
Figure 1Selected 1H–1H COSY (▬) and HMBC (→) correlations of 1, 2 and 5.
Figure 2Key NOESY correlations for 1 and 2.
Figure 3Key NOESY correlations for 5.
Cytotoxicity (ED50 μg/mL) of compounds 5, 6, 10 and 12.
| Cell Lines | Normal Cell Line | |||||
|---|---|---|---|---|---|---|
| Compounds | A549 | BT483 | H1299 | HepG2 | SAS | BEAS2B |
| 15.0 ± 3.5 | 11.5 ± 1.8 | 19.2 ± 4.0 | 12.9 ± 3.1 | 10.2 ± 3.5 | – a | |
| 16.1 ± 1.2 | 10.0 ± 1.8 | 11.8 ± 1.0 | – a | 17.2 ± 0.4 | 10.4 ± 0.3 | |
| 6.8 ± 1.0 | 11.6 ± 2.8 | 6.7 ± 0.7 | 8.5 ± 1.3 | 9.5 ± 3.7 | 4.8 ± 0.7 | |
| 12.2 ± 1.1 | 6.8 ± 0.6 | 12.8 ± 1.2 | 11.1 ± 0.4 | 10.3 ± 0.5 | 13.6 ± 0.5 | |
| Taxol | 1.5 ± 0.9 | 3.9 ± 0.8 | 1.2 ± 0.1 | 1.4 ± 0.7 | 2.3 ± 1.5 | 2.3 ± 1.5 |
a IC50 > 20 μg/mL.
Figure 4Effect of compounds 1–12 on LPS-induced iNOS and COX-2 proteins expression in RAW264.7 macrophage cells by immunoblot analysis. The values are mean ± SEM. (n = 6). Relative intensity of the LPS alone stimulated group was taken as 100%.* Significantly different from LPS alone stimulated group (* P < 0.05). a stimulated with LPS, b stimulated with LPS in the presence of 1–12 (10 μM).